杨毅治疗肺纤维化减撤糖皮质激素经验介绍
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R563

基金项目:

湖北省中医院昙华林名医、学子培养项目(鄂中医院字[2018]72号)


Experience Introduction of YANG Yi Treating Reduction and Removal of Glucocorti⁃ coid Caused by Pulmonary Fibrosis
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    介绍杨毅教授治疗肺纤维化减撤糖皮质激素的经验。从肺纤维化稳定期病机与减撤糖皮质激素阶段证型的相关性方面进行分析,认为:肺纤维化稳定期属中医肺痿范畴,基本病机为肺脏虚损,津气大伤,致肺叶枯萎不用;肺纤维化稳定期减撤激素阶段以气阴两虚为主证;当以益气健脾、滋阴固肾为基本法则,贯穿肺纤维化治疗始终。

    Abstract:

    Abstract: This paper introduces the experience of Professor YANG Yi in the treatment of reduction and withdrawal of glucocorticoid caused by pulmonary fibrosis. Based on the analysis of the correlation between the pathogenesis of pulmonary fibrosis at stable stage and the syndrome type at the stage of reducing and removing glucocorticoid, it is considered that pulmonary fibrosis at stable stage belongs to the category of lung atrophy in Chinese medicine,and the basic pathogenesis is lung deficiency and depletion with severe damage of fluid qi cause the withered lung lobe. In the phase of pulmonary fibrosis at stable stage reducing and removing glucocorticoid,the main syndrome is dual deficiency of qi and Yin;the basic principles should be replenishing qi and fortifying the spleen as well as enriching yin and securing the kidney, going throughout the treatment of pulmonary fibrosis.

    参考文献
    相似文献
    引证文献
引用本文

刘梦婷,指导:杨毅.杨毅治疗肺纤维化减撤糖皮质激素经验介绍[J].新中医,2021,53(14):205-207

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2021-07-24
  • 出版日期: